September 10, 2021

Call for papers: Magnetomotive photoacoustic in biomedical applications

Lead Guest Editor

Dr. Yuvaraja Teekaraman
Senior Researcher & Project Manager
MOBI-Mobility, Logistics and Automotive Technology Research Centre
Vrije Universiteit Brussel
Ixelles, Brussels, Belgium

https://mobi.research.vub.be/en/dr-yuvaraja-teekaraman

Guest Editors

Dr. Srete Nikolovski
Faculty of Electrical Engineering,
Computer Science and Information Technology,
University of Osijek, Croatia

https://www.ferit.unios.hr/fakultet/imenik-djelatnika/srete

Dr. Mohamed Yaseen Jabarulla
Researcher, INFONET Laboratory,
Gwangju Institute of Science and Technology,
School of Electrical Engineering and Computer Science, Gwangju, South Korea

https://heungno.net

 

Aims and Scope

Magnetic Fields are mostly used in today’s life, as well as in specific occupational environments. Biomedical imaging has been an essential tool in daily medical diagnostics. For more than 100 years, various biomedical imaging technologies have been developed to provide anatomical, functional and molecular information of internal organs, among which optical imaging and ultrasound imaging have been two major modalities. Being distinct in fundamental physics, optical imaging and ultrasound imaging have been explored by different research communities. In recent decades, the emergence of magnetomotive photoacoustic imaging (mmPA) modality has opened the way for integrating optical and ultrasound merits, i.e., rich optical contrast and deep ultrasound resolution. PAI has experienced an exponential increase in both research and industrial communities.

These achievements include but are not limited to: mmPA microscopy, mmPA tomography, mmPA endoscopy, mmPA intravascular probe, contrast-enhanced mmPA, and related physics, system and algorithm designs. Photoacoustic (or optoacoustic) imaging, including photoacoustic tomography (PAT) and photoacoustic microscopy (PAM), is an emerging imaging modality with great clinical potential. PAI’s deep tissue penetration and fine spatial resolution also hold great promise for visualizing physiology and pathology at the molecular level. PA combines optical contrast with the ultrasonic resolution and is capable of imaging at depths of up to 7 cm with a real-time scalable spatial resolution of 10 to 500 µm. PAI has demonstrated applications in brain imaging and cancer imaging such as breast cancer, prostate cancer, oval cancer, etc.

This Special Issue focuses on the novel technological developments and pre-clinical and clinical biomedical applications of PA.

Topics include, but are not limited to:

  • Brain imaging
  • Electromagnetic Bio Effects
  • Electromagnetic Field Modelling
  • Cancer imaging
  • Image reconstruction
  • Quantitative imaging
  • Light source and delivery for PAI
  • Photoacoustic detector
  • Nanoparticles designed for PAI
  • Photoacoustic molecular imaging
  • Photoacoustic spectroscopy
  • Biomedical imaging
  • Photoacoustic imaging
  • Thermo-acoustic imaging
  • Optical imaging
  • Ultrasound imaging
  • Acoustics
  • Biophotonics

 

Deadline and Submission Guidelines

The submission deadline for all papers is June 30, 2022.

Please, submit your article on https://www.publishingmanager.org/ by checking the box “Magnetomotive Photoacoustic In Biomedical Applications”. All articles will undergo a peer-review process as regularly submitted papers. The Fee for publication is Euro 1400,00.

Please, also check out our instructions for the authors before submission at the following link: https://www.staging.europeanreview.org/how-to-submit-an-article.

For further information, please, contact us at eurrev@gmail.com or the Guest Editors at the following email addresses:

Dr. Yuvaraja Teekaraman, email: Yuvaraja.Teekaraman@vub.be

Dr. Srete Nikolovski, email: srete.nikolovski@ferit.hr

Dr. Yaseen Mohamed, email: Yaseen@gm.gist.ac.kr

 

 

August 2, 2021

Call for papers: gut microbiota and chronic non-communicable diseases

Guest Editors

Prof. Dr. Annalisa Noce
UOC of Internal Medicine-Center of Hypertension and Nephrology Unit, Department of
Systems Medicine, University of Rome Tor Vergata, Rome, Italy

Dr. Maria Albanese
Neurology Unit, Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy

Dr. Giulia Marrone
UOC of Internal Medicine-Center of Hypertension and Nephrology Unit, Department of
Systems Medicine, University of Rome Tor Vergata, Rome, Italy

Aims and Scope

The term “gut microbiota” refers to the community of micro-organisms that colonize the human gastrointestinal tract. The gut microbiota is considered a well-known complex ecosystem composed of distinct microbial populations, playing a crucial role in human health. Several factors, such as type of birth, dietary habits, age, consumption of probiotics and prebiotics, use of antibiotics, intestinal comorbidities, and even metabolic diseases may continuously alter microbiota composition and its functions. The negative modulation of gut microbiota composition induces the dysbiosis condition. In fact, increasing evidence suggests that an imbalanced gut microbial composition and its activity, together with increased intestinal permeability, are able to cause alteration of several metabolic pathways and of the immune-system responses, contributing to developing several non-communicable chronic degenerative diseases (NCCDDs) (i.e., obesity, diabetes mellitus, cardiovascular diseases, arterial hypertension, obesity, chronic kidney diseases, neurodegenerative disorders).

Currently, the specific role of foods and their metabolites in the pathogenesis of these pathological conditions are yet to be established and the benefits of specific nutritional interventions, as suggested by pre-clinical trials, have not been fully determined.

This Special Issue will collect original articles and reviews focused on better understanding the role of gut microbiota composition on NCCDDs onset and progression.

Topics covered should include:

  • gut microbiota;
  • Mediterranean diet;
  • chronic non-communicable diseases;
  • metabolic pathways;
  • chronic kidney disease;
  • neurodegenerative diseases.

 

Deadline and Submission Guidelines

The submission deadline for all papers is June 30, 2022.

Please, submit your article on https://www.publishingmanager.org/ by checking the box “Special Issue – Gut Microbiota and Chronic Non-Communicable Diseases”. All articles will undergo a peer-review process as regularly submitted papers. The Fee for publication is Euro 1400,00.

Please, also check out our instructions for the authors before submission at the following link: https://www.staging.europeanreview.org/how-to-submit-an-article.

For further information, please, contact us at eurrev@gmail.com or the Guest Editors at the following email addresses:

Prof. Dr. Annalisa Noce, email: annalisa.noce@uniroma2.it

Dr. Maria Albanese, email: maria.albanese@hotmail.it

Dr. Giulia Marrone, email: giul.marr@gmail.com